Stocktoria
NIKA PHARMACEUTICALS, INC NIKA
OTC · stock · Pharmaceutical Preparations · website · IPO 2024-01-24
NIKA PHARMACEUTICALS, INC financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | $0 | — |
| Operating income | -$76,398 | -$95,792 | -$64,833 | -$3.2M | -$14,712 | -$8,907 |
| Net income | -$76,398 | -$95,792 | -$64,833 | -$3.2M | -$14,712 | -$8,907 |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Operating cash flow | -$79,654 | -$154,932 | -$64,833 | $33,715 | $14,712 | -$8,907 |
| Cash & equivalents | $1,889 | $2,083 | $19,596 | $864 | $399 | $1,611 |
| Total assets | $20,996 | $17,934 | $19,596 | $864 | $399 | $1,611 |
| Total liabilities | $318,624 | $239,164 | $101,745 | $18,180 | $24,018 | $10,518 |
| Shareholders' equity | -$297,628 | -$221,231 | -$82,149 | -$17,316 | -$23,619 | -$8,907 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.